Navigation Links
New drug proven to tackle Type 2 Diabetes

A new drug called Rosiglitazone capable of controlling Type 2 diabetes has been given the green signal by researchers, Researchers// content that this drug is capable of reported in The Lancet ,a renounced British medical journal . Researchers content that this drug is capable of reducing Type 2 Diabetes by 60%.

The results of a 3 year long study named DREAM(for Diabetes Reduction Approaches with Medication )conducted at Royal Victoria Hospital led by endocrinologist Jean-Francois Yale have shown that in every thousand cases of “pre-diabetes” treated with Rosiglitazone,144 new cases were prevented. The drug exhibited a capability to bring down blood sugar levels to normal. This 25 million dollar study which was funded by 3 drug companies and Canadian Institutes of Health Research studied 5,000 patients recruited from over 21 countries. Canada itself has a staggering 2 million diabetics currently and is expected to cross 3 million by year 2010.

Such a breakthrough would immensely benefit individuals with a strong history of Diabetes running in the family, or were either parent or both are already known diabetics. However it has to be kept in mind that predominantly it is only a well balanced diet and regular exercise that have been proven to pay rich dividends in controlling the late onset type of diabetes, as proven in research studies. Though currently rosiglitazone is being used only as a second line treatment for diabetics, it may soon be used as a front line therapy for nearly 8% of people with high blood sugar world wide.

Rosiglitazone is still not proven in its efficacy to stall onset of Diabetes in those who fall in the high risk group or if there could be a relapse of diabetes if it is withdrawn from a patient. Nearly 2 million Canadians are diabetic. The Canadian Diabetes Association predicts that number will rise to 3 million by 2010.

It's not known yet whether the drug prevents or delays diabetes or whether i ts effects disappear once patients stop treatment.


MS
'"/>




Related medicine news :

1. TELITHROMYCIN - the proven effective new drug for cap
2. Partial-Breast Irradiation an Unproven Therapy
3. The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs
4. Guidelines to tackle bird flu pandemic
5. U.S. unprepared to tackle bird flu
6. Meeting to tackle Chikungunya
7. AIDS to be tackled through Computer Games
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. Diabetes and Depression often go hand-in-hand
10. Thirty minutes of work up per day reduces the risk of Diabetes
11. Diabetes on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2017)... ... 2017 , ... Thinksport, the leaders in safe, non-toxic products, ... they’ve used the same scientific approach to solving smelly, sweaty athletes, by creating ... that contain harmful chemicals that should be put nowhere near your skin (phthalates, ...
(Date:4/27/2017)... ... April 27, 2017 , ... Last night, Christine ... of the Year for her extraordinary compassion and lifelong dedication to serve others. ... professional caregivers for the prestigious award each year – identifying a CAREGiver who ...
(Date:4/27/2017)... ... ... Goodcents Deli Fresh Subs announced a franchise expansion agreement today including three new ... first new location will open at the corner of 27th and Randolph in Lincoln, ... this fall. And the third location is in the process of being identified. ...
(Date:4/27/2017)... ... ... Are you investing in the safety of your friends and family? Each year, ... most of us assume this type of accident will never happen to us, the ... the time to learn how to respond effectively or prevent these accidents from occurring ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump ... hospitals, today announced it has completed a round of funding to accelerate its ... its partners. Black Granite Capital is a growth equity firm focused on investments ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, ... 2024" report to their offering. ... The global pharmacogenomics market was valued at US$ ... 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% ...
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: